相关实验视频

Updated: Jan 16, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

机械洞察力对年轻成年人的自我管理干预有刺激性肠综合征:一个试点多omics研究研究

Weizi Wu¹, Jie Chen², Aolan Li³

¹Yale School of Nursing, Orange, CT 06477, USA.

|September 27, 2025

概括

护士主导的干预措施通过改变肠道微生物和宿主基因表达来改善刺激性肠综合征 (IBS) 症状. 这项研究揭示了与IBS患者症状变化相关的特定宿主-微生物通路.

科学领域:

胃肠病学胃肠病学
微生物组研究的研究.
系统生物学系统生物学

背景情况:

刺激性肠综合征 (IBS) 管理依赖于自我指导的生活方式的改变.
了解IBS症状对干预措施的反应的生物机制至关重要.

研究的目的:

研究护士主导的自我管理干预后,在患有IBS的年轻成年人中,潜在的症状变化的多奥米克机制.
为了确定与症状改善相关的宿主-微生物通路变化.

主要方法:

一项为期12周的前后研究嵌入了一个随机对照试验.
收集的便和血液生物样本用于多omics分析 (宿主转录组学,肠道微生物组16SrRNA测序).
利用权重基因共同表达网络分析和线性混合效应模型将omics数据与临床结果关联起来.

主要成果:

该干预措施显著减少了IBS患者的疼痛严重程度和干扰.
在疼痛和微生物代谢途径之间发现了较少的关联.
焦虑与宿主转录基因能量代谢途径有关,而疲劳和睡眠障碍与免疫-炎症和微生物适应模块有关.

结论:

在IBS自我管理干预引起症状特异性的生物反应.
独特的宿主-微生物通路与IBS症状调节有关.
需要进一步的纵向研究来验证这些基于OMIC的IBS症状特征.

关键词:

刺激性肠综合征是什么意思多种主题的多种主题.精准医学是一门精准医学.自己管理干预的干预.

更多相关视频

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...